Cite
Reinke SN, Naz S, Chaleckis R, et al. Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. Eur Respir J. 2021;doi: 10.1183/13993003.01733-2021.
Reinke, S. N., Naz, S., Chaleckis, R., Gallart-Ayala, H., Kolmert, J., Kermani, N. Z., Tiotiu, A., Broadhurst, D. I., Lundqvist, A., Olsson, H., Ström, M., Wheelock, �. �. M., Gómez, C., Ericsson, M., Sousa, A. R., Riley, J. H., Bates, S., Scholfield, J., Loza, M., Baribaud, F., Bakke, P. S., Caruso, M., Chanez, P., Fowler, S. J., Geiser, T., Howarth, P., Horváth, I., Krug, N., Montuschi, P., Behndig, A., Singer, F., Musial, J., Shaw, D. E., Dahlén, B., Hu, S., Lasky-Su, J., Sterk, P. J., Chung, K. F., Djukanovic, R., Dahlén, S. E., Adcock, I. M., Wheelock, C. E. (2021). Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. The European respiratory journal, . https://doi.org/10.1183/13993003.01733-2021
Reinke, Stacey N, et al. "Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.01733-2021
Reinke SN, Naz S, Chaleckis R, Gallart-Ayala H, Kolmert J, Kermani NZ, Tiotiu A, Broadhurst DI, Lundqvist A, Olsson H, Ström M, Wheelock ÅM, Gómez C, Ericsson M, Sousa AR, Riley JH, Bates S, Scholfield J, Loza M, Baribaud F, Bakke PS, Caruso M, Chanez P, Fowler SJ, Geiser T, Howarth P, Horváth I, Krug N, Montuschi P, Behndig A, Singer F, Musial J, Shaw DE, Dahlén B, Hu S, Lasky-Su J, Sterk PJ, Chung KF, Djukanovic R, Dahlén SE, Adcock IM, Wheelock CE. Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. Eur Respir J. 2021 Nov 25; doi: 10.1183/13993003.01733-2021. Epub 2021 Nov 25. PMID: 34824054.
Copy
Download .nbib